Acute exacerbation of idiopathic pulmonary fibrosis after bivalent {tozinameran and famtozinameran} mRNA COVID-19 vaccination

被引：0
作者：
Tsumura, Kenji [1 ]
Zaizen, Yoshiaki [1 ,2 ]
Umemoto, Shushi [1 ]
Tsuneyoshi, Shingo [1 ]
Matama, Goushi [1 ]
Okamoto, Masaki [1 ,3 ,4 ]
Tominaga, Masaki [1 ,5 ]
Hoshino, Tomoaki [1 ]
机构：
[1] Kurume Univ, Dept Med, Div Respirol Neurol & Rheumatol, Sch Med, 67 Asahi Machi, Kurume, Fukuoka 8300011, Japan
[2] Nagasaki Univ, Dept Pathol Informat, Grad Sch Biomed Sci, 1-7-1 Sakamoto, Nagasaki 8528501, Japan
[3] Natl Hosp Org, Dept Respirol, Kyushu Med Ctr, 1-8-1 Jigyouhama,Chuo Ku, Fukuoka 8108563, Japan
[4] Natl Hosp Org, Clin Res Ctr, Kyushu Med Ctr, 1-8-1 Jigyouhama,Chuo Ku, Fukuoka 8108563, Japan
[5] Kurume Univ, Dept Community Med, Sch Med, 67 Asahi Machi, Kurume, Fukuoka 8300011, Japan
来源：
RESPIRATORY MEDICINE CASE REPORTS | 2023年 / 46卷
关键词：
Idiopathic interstitial pneumonia; Acute exacerbation; COVID-19; vaccine; Tozinameran; Famtozinameran; DIAGNOSIS; UPDATE;
D O I：
10.1016/j.rmcr.2023.101960
中图分类号：
R56 [呼吸系及胸部疾病];
学科分类号：
摘要：
An 82-year-old man diagnosed with interstitial lung disease through computed tomography (CT) 1 year prior received a bivalent (tozinameran and famtozinameran) mRNA COVID-19 vaccine. He developed respiratory symptoms 1.5 months later, and chest high-resolution CT revealed new ground-glass opacities showing traction bronchiectasis. Transbronchial lung cryobiopsy revealed organizing acute lung injury and fibrosis with architectural destruction. The patient was diagnosed with an acute exacerbation of idiopathic pulmonary fibrosis (AE-IPF). The bivalent mRNA COVID-19 vaccination was determined as the cause of the AE-IPF based on detailed medical history and examination findings. High-dose corticosteroid therapy improved the patient's symptoms and radiological findings.
引用
收藏
页数：5
相关论文
共 19 条
  • [11] Guidelines of the Polish Respiratory Society for diagnosis and treatment of idiopathic pulmonary fibrosis
    Piotrowski, Wojciech J.
    Bestry, Iwona
    Bialas, Adam J.
    Boros, Piotr W.
    Grzanka, Piotr
    Jassem, Ewa
    Jastrzebski, Dariusz
    Klimczak, Dariusz
    Langfort, Renata
    Lewandowska, Katarzyna
    Majewski, Sebastian
    Martusewicz-Boros, Magdalena M.
    Oniszh, Karina
    Puscinska, Elzbieta
    Sieminska, Alicja
    Sobiecka, Malgorzata
    Szolkowska, Malgorzata
    Wiatr, Elzbieta
    Wilczynski, Gracjan
    Ziora, Dariusz
    Kus, Jan
    [J]. ADVANCES IN RESPIRATORY MEDICINE, 2020, 88 (01) : 41 - 93
  • [12] Raghu G., 2018, Am. J. Respir. Crit. Care Med., Japan. Respirat. Soc, V198, pe44, DOI [10.1164/rccm.201807-1255ST, DOI 10.1164/RCCM.201807-1255ST]
  • [13] Idiopathic Pulmonary Fibrosis (an Update) and Progressive Pulmonary Fibrosis in Adults An Official ATS/ERS/JRS/ALAT Clinical Practice Guideline
    Raghu, Ganesh
    Remy-Jardin, Martine
    Richeldi, Luca
    Thomson, Carey C.
    Inoue, Yoshikazu
    Johkoh, Takeshi
    Kreuter, Michael
    Lynch, David A.
    Maher, Toby M.
    Martinez, Fernando J.
    Molina-Molina, Maria
    Myers, Jeffrey L.
    Nicholson, Andrew G.
    Ryerson, Christopher J.
    Strek, Mary E.
    Troy, Lauren K.
    Wijsenbeek, Marlies
    Mammen, Manoj J.
    Hossain, Tanzib
    Bissell, Brittany D.
    Herman, Derrick D.
    Hon, Stephanie M.
    Kheir, Fayez
    Khor, Yet H.
    Macrea, Madalina
    Antoniou, Katerina M.
    Bouros, Demosthenes
    Buendia-Roldan, Ivette
    Caro, Fabian
    Crestani, Bruno
    Ho, Lawrence
    Morisset, Julie
    Olson, Amy L.
    Podolanczuk, Anna
    Poletti, Venerino
    Selman, Moises
    Ewing, Thomas
    Jones, Stephen
    Knight, Shandra L.
    Ghazipura, Marya
    Wilson, Kevin C.
    [J]. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2022, 205 (09) : E18 - E47
  • [14] An Official ATS/ERS/JRS/ALAT Clinical Practice Guideline: Treatment of Idiopathic Pulmonary Fibrosis An Update of the 2011 Clinical Practice Guideline
    Raghu, Ganesh
    Rochwerg, Bram
    Zhang, Yuan
    Garcia, Carlos A. Cuello
    Azuma, Arata
    Behr, Juergen
    Brozek, Jan L.
    Collard, Harold R.
    Cunningham, William
    Homma, Sakae
    Johkoh, Takeshi
    Martinez, Fernando J.
    Myers, Jeffrey
    Protzko, Shandra L.
    Richeldi, Luca
    Rind, David
    Selman, Moises
    Theodore, Arthur
    Wells, Athol U.
    Hoogsteden, Henk
    Schuenemann, Holger J.
    [J]. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2015, 192 (02) : E3 - E19
  • [15] Incidence of acute exacerbation in patients with interstitial lung disease after COVID-19 vaccination
    Sakayori, Masashi
    Hagiwara, Eri
    Baba, Tomohisa
    Kitamura, Hideya
    Sekine, Akimasa
    Ikeda, Satoshi
    Tabata, Erina
    Yamada, Sho
    Fujimoto, Kazushi
    Ogura, Takashi
    [J]. JOURNAL OF INFECTION AND CHEMOTHERAPY, 2023, 29 (01) : 105 - 108
  • [16] Acute exacerbation of interstitial pneumonia associated with collagen vascular diseases
    Suda, Takafumi
    Kaida, Yusuke
    Nakamura, Yutaro
    Enomoto, Noriyuki
    Fujisawa, Tomoyuki
    Imokawa, Shiro
    Hashizume, Hideo
    Naito, Tateaki
    Hashimoto, Dai
    Takehara, Yasuo
    Inui, Naoki
    Nakamura, Hirotoshi
    Colby, Thomas V.
    Chida, Kingo
    [J]. RESPIRATORY MEDICINE, 2009, 103 (06) : 846 - 853
  • [17] Acute Exacerbation of Interstitial Lung Disease After SARS-CoV-2 Vaccination A Case Series
    Tasaka, Sadatomo
    Ishioka, Yoshiko
    Makiguchi, Tomonori
    Itoga, Masamichi
    Tanaka, Hisashi
    Taima, Kageaki
    Goto, Shintaro
    [J]. CHEST, 2022, 162 (06) : E311 - E316
  • [18] Zaizen Yoshiaki, 2020, Surg Pathol Clin, V13, P91, DOI 10.1016/j.path.2019.11.006
  • [19] SARS-CoV-2 spike protein interacts with and activates TLR41
    Zhao, Yingchi
    Kuang, Ming
    Li, Junhong
    Zhu, Ling
    Jia, Zijing
    Guo, Xuefei
    Hu, Yaling
    Kong, Jun
    Yin, Hang
    Wang, Xiangxi
    You, Fuping
    [J]. CELL RESEARCH, 2021, 31 (07) : 818 - 820
12